![David H. Peyton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David H. Peyton
Corporate Officer/Principal at Portland State University
David H. Peyton active positions
Companies | Position | Start | End |
---|---|---|---|
Portland State University | Corporate Officer/Principal | 2009-10-29 | - |
Career history of David H. Peyton
Former positions of David H. Peyton
Companies | Position | Start | End |
---|---|---|---|
DesignMedix, Inc.
![]() DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Founder | 2005-12-31 | - |
Training of David H. Peyton
Abilene Christian University | Undergraduate Degree |
University of California, Santa Barbara | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
DesignMedix, Inc.
![]() DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Health Technology |
- Stock Market
- Insiders
- David H. Peyton
- Experience